The group of companies “Biotek” is a new drug “Nimesulide-ICF”. The drug belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibiting... GK “Biotek” has submitted a new drug from the group of NSAIDs

The group of companies “Biotek” is a new drug “Nimesulide-ICF”. The drug belongs to the group of nonsteroidal anti-inflammatory drugs (NSAIDs) that selectively inhibiting COX-2. Available in a new dosage form – granules for suspension.

Nimesulide-MBF allowed for the symptomatic treatment of acute pain (back pain, musculoskeletal system, dental pain), symptomatic treatment of osteoarthritis and primary algodismenorea.

Granules for suspension packaged in 5, 10, 20 or 30 sachets, each of which contains a single dose of the drug. Before taking the contents paketika dissolve in 100 ml of water at room temperature. Dispensed by prescription.

Industrial production of the drug “Nimesulide-MBF” carries out JSC “Marbiopharm”, production site of GC “Biotec”.

Source: GK “Biotek”

No comments so far.

Be first to leave comment below.

Your email address will not be published. Required fields are marked *